Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Viking Therapeutics Inc shares valued at $29,943 were purchased by Rouan Sarah Kathryn on Mar 31 ’25. At $24.15 per share, Rouan Sarah Kathryn acquired 1,240 shares. The insider’s holdings grew to 1,240 shares worth approximately $34372.799999999996 following the completion of this transaction.
Also, Lian Brian sold 194,490 shares, netting a total of over 8,313,601 in proceeds. Following the sale of shares at $42.75 each, the insider now holds 2,366,570 shares.
Before that, Mancini Marianna had sold 54,215 shares from its account. In a trade valued at $2,317,599, the Chief Operating Officer traded Viking Therapeutics Inc shares for $42.75 each. Upon closing the transaction, the insider’s holdings decreased to 54,215 shares, worth approximately $10.37 million.
As published in their initiating research note from Cantor Fitzgerald on April 29, 2025, Viking Therapeutics Inc [VKTX] has been an Overweight and the price target has been revised to $104. Analysts at Goldman started covering the stock with ‘”a Neutral”‘ outlook in a report released in early April. As of February 13, 2025, Scotiabank has initiated its “Sector outperform” rating for VKTX. Earlier on February 07, 2025, Citigroup initiated its rating. Their recommendation was “a Neutral” for VKTX stock.
Analyzing VKTX Stock Performance
On last trading session,, Viking Therapeutics Inc [NASDAQ: VKTX] rose 3.94% to $27.72. The stock’s lowest price that day was $26.5833, but it reached a high of $28.8 in the same session. During the last five days, there has been a surge of approximately 2.33%. Over the course of the year, Viking Therapeutics Inc shares have dropped approximately -47.71%. Shares of the company reached a 52-week high of $43.55 on 01/06/25 and a 52-week low of $18.92 on 04/09/25.
Support And Resistance Levels for Viking Therapeutics Inc (VKTX)
According to the 24-hour chart, there is a support level at 26.60, which, if violated, would cause prices to drop to 25.48. In the upper region, resistance lies at 28.82. The next price resistance is at 29.92. RSI (Relative Strength Index) is 53.36 on the 14-day chart, showing neutral technical sentiment.
Is Viking Therapeutics Inc subject to short interest?
Stocks of Viking Therapeutics Inc saw a sharp rise in short interest on 2025-06-13 jumping by 2.93 million shares to 28.47 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 25.54 million shares. A jump of 10.29% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 9.61 of the overall float, the days-to-cover ratio (short ratio) jumped to 9.61.
Which companies own the most shares of Viking Therapeutics Inc (VKTX)?
In terms of Viking Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 75 in the next 12 months, up nearly 181.21% from the previous closing price of $26.67. Analysts anticipate Viking Therapeutics Inc stock to reach 75 by 2025, with the lowest price target being 75. In spite of this, 7 analysts ranked Viking Therapeutics Inc stock as Buy at the end of 2025.
